2010P Trifunctional anti-EpCAM/CD3 bsAb catumaxomab intravesically for high and intermediate risk non muscle invasive bladder cancer (HMR-NMIBC): Interim analysis of a phase I study
| Autor: | Antoniewicz, A.A., Albert, F., Wessels, F., Lenhart, M., Neuberger, M., Ruf, P., Lindhofer, H., Oberneder, R., Kriegmair, M. |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S1160-S1160 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|